Last Updated 04-14-08  
a m e r i c a n s t a t i s t i c a l a s s o c i a t i o n


charter
Operations Manual
committee
members
Biopharm Report
workshops
awards




more info
join





Maintained by D. Christen
© ASA Biopharmaceutical Section

 


We gratefully acknowledge our Corporate Sponsors for their support to the Section:
Abt Associates Allergan Amgen, Inc. Averion, Inc.
Biogen – IDEC Boehringer Ingelheim Pharmaceuticals Boston Scientific Bristol-Myers Squibb
Centocor, Inc. Cytel Software, Corp. Eli Lilly & Co GlaxoSmith Kline
Hoffman-LaRoche, Inc. ICON Clinical Research Insightful Corp. Johnson & Johnson, PRD.
Merck & Co., Inc. Novartis Pharmaceuticals Pfizer, Inc. Proctor & Gamble Pharmaceuticals
Quintiles Innovex RHO Inc. Sanofi – Aventis SAS Institute
Schering-Plough Res. Inst. Takeda Pharmaceutical Company Waban Software Wyeth Consumer Healthcare
If your company wants to be a corporate sponsor, please click here.

What's New?

02/08/08:

    Biopharmaceutical Section – Student Paper Award 2008 Submission Guidelines:
    Student paper awards are presented annually at the JSM meeting for student research papers with statistical content applicable to the Biopharmaceutical arena. The categories for scoring are clarity, contribution to statistics, and biopharmaceutical applicability. Suitable topics include but are not limited to methodological issues in preclinical or clinical trials, epidemiology studies of drug (or device or biological) safety, genetic studies predicting drug (or biological) response, laboratory and toxicological data analyses, methods for high-dimensional data from high-throughput screening, and non-linear pharmacokinetic modeling.

    The following guidelines will help in making the judging process fair and unbiased:

  • Submissions should be labeled as a “student paper submission” and sent to Kalyan Ghosh, Program Chair for the Biopharmaceutical Section, kalyan.ghosh@vislation.com ·
  • Submissions of papers for consideration must be received electronically in WORD format. ·
  • In order to facilitate blinding, the student’s name should appear only on the first page, names for references should not be included in the text (numbers for references used in text, names on reference page only). References, which would un-blind a reviewer to the student’s name or the student’s advisor/collaborator will be removed for the review. ·
  • The length of the paper should not exceed 15 pages of double-spaced type of text with no more than 5 additional pages of appendices (20 pages maximum). Please consider a manuscript style for the paper to facilitate publication in the proceedings for JSM or in another appropriate journal. ·
  • Deadline for submission is March 31st, 2008.

04/14/08:

  • Updated 'Executive Committee' Section

08/10/07:

06/04/07:

  • Summer 2007 (br_sum07.pdf) issue of the Biopharmaceutical Report has been issued and is available

05/14/07:

04/04/07:

02/01/07:

12/13/06:

11/10/06:

  • The Membership list has been updated

11/03/06:

  • The Fall 2006 issue of the Biopharmaceutical Report is available

10/26/06:

  • The ASA Biopharmaceutical Section executive committee will have its annual transition meeting on Friday, Nov 17, at ASA headquarters in Alexandria, Virginia, with telephone dial-in available to those unable to travel to this meeting.

10/06/06:

  • Updated ASA Biopharm Section's Corporate Sponsorship List




ASA HOMEPAGE || CHARTER || OPERATIONS MANUAL || EXECUTIVE COMMITTEE || MEMBERSHIP
BIOPHARM REPORT || WORKSHOPS || AWARDS || MORE INFO || PAST ACTIVITIES || FEEDBACK